Antidiabetic medication-induced acute interstitial nephritis: case report and literature search

被引：2

作者：

Chaudhury, Nadia Tai ^{[1
]}

Liarakos, Alexandros L. ^{[1
]}

Gopalakrishnan, Kishore ^{[2
]}

Ayub, Waqar ^{[3
]}

Murthy, Narasimha ^{[1
]}

Rao, Ranganatha ^{[1
]}

机构：

[1] Univ Hosp Coventry & Warwickshire NHS Trust, WISDEM Ctr, Dept Endocrinol & Diabet, Coventry, W Midlands, England

[2] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Histopathol, Coventry, W Midlands, England

[3] Univ Hosp Coventry & Warwickshire NHS Trust, Dept Renal Med, Coventry, W Midlands, England

来源：

BRITISH JOURNAL OF DIABETES | 2021年 / 21卷 / 02期

关键词：

GLP-1 receptor agonists; liraglutide; renal impairment; acute kidney injury; nephrology; renal; diabetes; ACUTE TUBULOINTERSTITIAL NEPHRITIS; ACUTE-RENAL-FAILURE; LIRAGLUTIDE; ROSIGLITAZONE; PREVALENCE; OUTCOMES; EVENTS;

D O I：

10.15277/bjd.2021.321

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：228 / 232

页数：5

共 39 条

[1]

Akbar S, 2010, AM J KIDNEY DIS, V55, pA36

[2]

Alsaad Ali A, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-216297

[3]

Bhatti R., 2010, Pract. Diabetes Int., V27, P232, DOI DOI 10.1002/PDI.1493

[4]

Bnaya A, 2020, NEPHROL DIAL TRANSPL, V35, P900

[5] Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) Trials [J].

Buse, John B. ;

Garber, Alan ;

Rosenstock, Julio ;

Schmidt, Wolfgang E. ;

Brett, Jason H. ;

Videbaek, Nicoline ;

Holst, Jens ;

Nauck, Michael .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (06) :1695-1702

[6] Rosiglitazone as a cause of acute interstitial nephritis [J].

Castledine, Clare ;

Wright, David ;

Kingdon, Edward .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (07) :1994-1995

[7] Acute interstitial nephritis: clinical features and response to corticosteroid therapy [J].

Clarkson, MR ;

Giblin, L ;

O'Connell, FP ;

O'Kelly, P ;

Walshe, JJ ;

Conlon, P ;

O'Meara, Y ;

Dormon, A ;

Campbell, E ;

Donohoe, J .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (11) :2778-2783

[8] Efficacy and Safety of Liraglutide Versus Placebo as Add-on to Glucose-Lowering Therapy in Patients With Type 2 Diabetes and Moderate Renal Impairment ( LIRA-RENAL): A Randomized Clinical Trial [J].

Davies, Melanie J. ;

Bain, Stephen C. ;

Atkin, Stephen L. ;

Rossing, Peter ;

Scott, David ;

Shamkhalova, Minara S. ;

Bosch-Traberg, Heidrun ;

Syren, Annika ;

Umpierrez, Guillermo E. .

DIABETES CARE, 2016, 39 (02) :222-230

[9] Severe acute renal failure in patients treated with glucagon-like peptide-1 receptor agonists [J].

Dubois-Laforgue, D. ;

Boutboul, D. ;

Levy, D. J. ;

Joly, D. ;

Timsit, J. .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2014, 103 (03) :E53-E55

[10] Steroid hyperglycemia: Prevalence, early detection and therapeutic recommendations: A narrative review [J].

Eloy Tamez-Perez, Hector ;

Lizet Quintanilla-Flores, Dania ;

Rodriguez-Gutierrez, Rene ;

Gerardo Gonzalez-Gonzalez, Jose ;

Lorena Tamez-Pena, Alejandra .

WORLD JOURNAL OF DIABETES, 2015, 6 (08) :1073-1081

← 1 2 3 4 →